Myocardial Ischemia Secondary to Synthetic Cannabinoid (K2) Use in Pediatric Patients.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 26165442.
- Also identified by DOI 10.1016/j.jpeds.2015.06.001.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
K2 is a synthetic cannabinoid that has potential cardiovascular side effects, including myocardial ischemia, myocardial infarction, and arrhythmias. Cardiac testing of pediatric patients is often not performed owing to a lack of symptomatology. We report a series of pediatric patients with concern for myocardial ischemia temporally associated with K2 exposure.
Medical subject headings
- Cannabinoids
- Designer Drugs
- Myocardial Ischemia